

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.25711845 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.25711845 |
| 3 | cerebellar granule cell differentiation (GO:0021707) | 4.03434192 |
| 4 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.02836149 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.98311049 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 3.98311049 |
| 7 | positive regulation of fibroblast migration (GO:0010763) | 3.96396297 |
| 8 | glomerular visceral epithelial cell development (GO:0072015) | 3.90114878 |
| 9 | glutamate secretion (GO:0014047) | 3.65227939 |
| 10 | synaptic vesicle maturation (GO:0016188) | 3.62253976 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 3.56812672 |
| 12 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.56168117 |
| 13 | regulation of platelet aggregation (GO:0090330) | 3.55128751 |
| 14 | L-amino acid import (GO:0043092) | 3.52557734 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.51795558 |
| 16 | platelet aggregation (GO:0070527) | 3.48232790 |
| 17 | adenosine receptor signaling pathway (GO:0001973) | 3.45615029 |
| 18 | locomotory exploration behavior (GO:0035641) | 3.45397297 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 3.45098614 |
| 20 | glomerular epithelial cell development (GO:0072310) | 3.42329673 |
| 21 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.41704757 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.40283298 |
| 23 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.37688759 |
| 24 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.34780688 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.34697166 |
| 26 | bile acid biosynthetic process (GO:0006699) | 3.33832986 |
| 27 | amino acid import (GO:0043090) | 3.31317572 |
| 28 | synaptic vesicle endocytosis (GO:0048488) | 3.27680858 |
| 29 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.21001547 |
| 30 | vocalization behavior (GO:0071625) | 3.18913593 |
| 31 | vesicle docking involved in exocytosis (GO:0006904) | 3.17404841 |
| 32 | positive regulation of neurotransmitter transport (GO:0051590) | 3.15451168 |
| 33 | regulation of neurotransmitter secretion (GO:0046928) | 3.14491532 |
| 34 | negative regulation of heart contraction (GO:0045822) | 3.14389493 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.14369248 |
| 36 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.14156312 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12658284 |
| 38 | neurotransmitter secretion (GO:0007269) | 3.11533899 |
| 39 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.11227483 |
| 40 | gamma-aminobutyric acid transport (GO:0015812) | 3.10893336 |
| 41 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.10252943 |
| 42 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.09967319 |
| 43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.06747703 |
| 44 | regulation of ARF protein signal transduction (GO:0032012) | 3.04095249 |
| 45 | glutamate metabolic process (GO:0006536) | 3.03257807 |
| 46 | kynurenine metabolic process (GO:0070189) | 3.03184960 |
| 47 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.02703138 |
| 48 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.01557973 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 3.01282091 |
| 50 | neuronal action potential propagation (GO:0019227) | 3.00589694 |
| 51 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.00566931 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 2.97052960 |
| 53 | tryptophan catabolic process (GO:0006569) | 2.95268550 |
| 54 | indole-containing compound catabolic process (GO:0042436) | 2.95268550 |
| 55 | indolalkylamine catabolic process (GO:0046218) | 2.95268550 |
| 56 | relaxation of smooth muscle (GO:0044557) | 2.94119919 |
| 57 | neuronal ion channel clustering (GO:0045161) | 2.93724628 |
| 58 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.89288310 |
| 59 | regulation of fibrinolysis (GO:0051917) | 2.87369362 |
| 60 | potassium ion homeostasis (GO:0055075) | 2.87238937 |
| 61 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.86367580 |
| 62 | regulation of early endosome to late endosome transport (GO:2000641) | 2.85098442 |
| 63 | drug catabolic process (GO:0042737) | 2.84687109 |
| 64 | vesicle docking (GO:0048278) | 2.83284063 |
| 65 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.82733071 |
| 66 | protein localization to synapse (GO:0035418) | 2.82694950 |
| 67 | positive regulation of receptor recycling (GO:0001921) | 2.82547323 |
| 68 | coenzyme catabolic process (GO:0009109) | 2.81683880 |
| 69 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.80533455 |
| 70 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.79779176 |
| 71 | regulation of neurotransmitter transport (GO:0051588) | 2.79162096 |
| 72 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.78796482 |
| 73 | regulation of protein activation cascade (GO:2000257) | 2.78612145 |
| 74 | urea metabolic process (GO:0019627) | 2.77540746 |
| 75 | urea cycle (GO:0000050) | 2.77540746 |
| 76 | regulation of synaptic vesicle transport (GO:1902803) | 2.77488969 |
| 77 | glomerular basement membrane development (GO:0032836) | 2.77169375 |
| 78 | bile acid metabolic process (GO:0008206) | 2.77020952 |
| 79 | activation of protein kinase A activity (GO:0034199) | 2.76656699 |
| 80 | exploration behavior (GO:0035640) | 2.76088568 |
| 81 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.76051992 |
| 82 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.75759405 |
| 83 | cellular potassium ion homeostasis (GO:0030007) | 2.75199983 |
| 84 | exogenous drug catabolic process (GO:0042738) | 2.74920525 |
| 85 | reverse cholesterol transport (GO:0043691) | 2.72920049 |
| 86 | response to gravity (GO:0009629) | 2.71442575 |
| 87 | sodium ion export (GO:0071436) | 2.70768305 |
| 88 | neuromuscular process controlling balance (GO:0050885) | 2.70171008 |
| 89 | potassium ion import (GO:0010107) | 2.69586506 |
| 90 | dicarboxylic acid catabolic process (GO:0043649) | 2.68744461 |
| 91 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.68689491 |
| 92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.68629813 |
| 93 | protein carboxylation (GO:0018214) | 2.68629813 |
| 94 | glyoxylate metabolic process (GO:0046487) | 2.67851743 |
| 95 | tryptophan metabolic process (GO:0006568) | 2.66948463 |
| 96 | thrombin receptor signaling pathway (GO:0070493) | 2.65376379 |
| 97 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.64990710 |
| 98 | negative regulation of protein activation cascade (GO:2000258) | 2.63610864 |
| 99 | negative regulation of cholesterol transport (GO:0032375) | 2.61473206 |
| 100 | negative regulation of sterol transport (GO:0032372) | 2.61473206 |
| 101 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61361864 |
| 102 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.60215780 |
| 103 | neuron cell-cell adhesion (GO:0007158) | 2.59881721 |
| 104 | positive regulation of synapse maturation (GO:0090129) | 2.59844170 |
| 105 | regulation of complement activation (GO:0030449) | 2.58663551 |
| 106 | macromolecular complex remodeling (GO:0034367) | 2.58077876 |
| 107 | plasma lipoprotein particle remodeling (GO:0034369) | 2.58077876 |
| 108 | protein-lipid complex remodeling (GO:0034368) | 2.58077876 |
| 109 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.57717059 |
| 110 | ketone body metabolic process (GO:1902224) | 2.57702360 |
| 111 | regulation of sensory perception of pain (GO:0051930) | 2.57644895 |
| 112 | regulation of sensory perception (GO:0051931) | 2.57644895 |
| 113 | neuron recognition (GO:0008038) | 2.56936258 |
| 114 | extracellular fibril organization (GO:0043206) | 2.54975381 |
| 115 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.54886157 |
| 116 | proline transport (GO:0015824) | 2.54280295 |
| 117 | complement activation, alternative pathway (GO:0006957) | 2.53678207 |
| 118 | tyrosine metabolic process (GO:0006570) | 2.53068150 |
| 119 | lysine metabolic process (GO:0006553) | 2.52908868 |
| 120 | lysine catabolic process (GO:0006554) | 2.52908868 |
| 121 | regulation of cholesterol esterification (GO:0010872) | 2.52893884 |
| 122 | relaxation of muscle (GO:0090075) | 2.52716441 |
| 123 | nitrogen cycle metabolic process (GO:0071941) | 2.52425163 |
| 124 | synaptic transmission, glutamatergic (GO:0035249) | 2.52383433 |
| 125 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.52037814 |
| 126 | positive regulation of membrane potential (GO:0045838) | 2.51867278 |
| 127 | cell communication involved in cardiac conduction (GO:0086065) | 2.51773937 |
| 128 | negative regulation of blood circulation (GO:1903523) | 2.51188503 |
| 129 | neuromuscular process controlling posture (GO:0050884) | 2.50102022 |
| 130 | cysteine metabolic process (GO:0006534) | 2.49097819 |
| 131 | negative regulation of heart rate (GO:0010459) | 2.47561636 |
| 132 | regulation of synapse structural plasticity (GO:0051823) | 2.47459330 |
| 133 | alpha-amino acid catabolic process (GO:1901606) | 2.46201088 |
| 134 | platelet degranulation (GO:0002576) | 2.45660278 |
| 135 | aromatic amino acid family metabolic process (GO:0009072) | 2.45357007 |
| 136 | homotypic cell-cell adhesion (GO:0034109) | 2.45135906 |
| 137 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.44908540 |
| 138 | sulfur amino acid catabolic process (GO:0000098) | 2.43939026 |
| 139 | beta-amyloid metabolic process (GO:0050435) | 2.43346199 |
| 140 | neurotransmitter transport (GO:0006836) | 2.43000783 |
| 141 | regulation of neurotransmitter levels (GO:0001505) | 2.41712369 |
| 142 | membrane depolarization during action potential (GO:0086010) | 2.41026044 |
| 143 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.40701937 |
| 144 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.39899000 |
| 145 | neuron-neuron synaptic transmission (GO:0007270) | 2.38987730 |
| 146 | dendritic spine organization (GO:0097061) | 2.38750572 |
| 147 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.38730142 |
| 148 | glutamate receptor signaling pathway (GO:0007215) | 2.37636373 |
| 149 | postsynaptic membrane organization (GO:0001941) | 2.37446638 |
| 150 | regulation of female receptivity (GO:0045924) | 2.37238077 |
| 151 | positive regulation of dendritic spine development (GO:0060999) | 2.37114509 |
| 152 | cholesterol efflux (GO:0033344) | 2.36170639 |
| 153 | regulation of synaptic transmission (GO:0050804) | 2.36074504 |
| 154 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.35635133 |
| 155 | acidic amino acid transport (GO:0015800) | 2.34759749 |
| 156 | phospholipid efflux (GO:0033700) | 2.34500704 |
| 157 | cellular sodium ion homeostasis (GO:0006883) | 2.34378900 |
| 158 | cellular modified amino acid catabolic process (GO:0042219) | 2.33514326 |
| 159 | regulation of platelet activation (GO:0010543) | 2.33228620 |
| 160 | negative regulation of adherens junction organization (GO:1903392) | 2.32795294 |
| 161 | negative regulation of cell junction assembly (GO:1901889) | 2.32795294 |
| 162 | regulation of synaptic plasticity (GO:0048167) | 2.32514225 |
| 163 | short-chain fatty acid metabolic process (GO:0046459) | 2.32018324 |
| 164 | cell communication by electrical coupling (GO:0010644) | 2.31426158 |
| 165 | cellular amino acid catabolic process (GO:0009063) | 2.30536969 |
| 166 | triglyceride homeostasis (GO:0070328) | 2.29963956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.28053484 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.90063374 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.73686125 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71028019 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.63466839 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.59161564 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.58630195 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.32871970 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.31322735 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.31322735 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28543323 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.22648613 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.22547581 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.21549165 |
| 15 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19417438 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.17280670 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15170414 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.14825734 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.14590625 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.07623404 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97371718 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.93672948 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.92258265 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.83695066 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.80278893 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77029457 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69059873 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68909132 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.66858513 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.66577415 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.66404673 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.60801810 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.59408166 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59251880 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59063318 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.57502239 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55128812 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54850717 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46050461 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45777890 |
| 41 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.40739648 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39574363 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38575273 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37704986 |
| 45 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37390676 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34845624 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33479094 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30239733 |
| 49 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29967660 |
| 50 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29090097 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27040388 |
| 52 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.26612337 |
| 53 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26085423 |
| 54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23107440 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22424932 |
| 56 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21934339 |
| 57 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21556683 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20543322 |
| 59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20209150 |
| 60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19036501 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18780050 |
| 62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17868528 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16837352 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16282420 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15196735 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14851981 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14069848 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13468847 |
| 69 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.12577511 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12511241 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12365145 |
| 72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12235132 |
| 73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11783074 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10961576 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09265543 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07001245 |
| 77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06592176 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06205252 |
| 79 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.05663682 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04359161 |
| 81 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03507811 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02867262 |
| 83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02697993 |
| 84 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00844265 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00120538 |
| 86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99896523 |
| 87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99769674 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99652482 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99115966 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99057990 |
| 91 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.98990337 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98907726 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98208335 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98083574 |
| 95 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97346991 |
| 96 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.96954042 |
| 97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96507268 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95668300 |
| 99 | AR_19668381_ChIP-Seq_PC3_Human | 0.95471241 |
| 100 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95373263 |
| 101 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95185581 |
| 102 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95067219 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.94540457 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93747568 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93693117 |
| 106 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.93656531 |
| 107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93255310 |
| 108 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92933753 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92194940 |
| 110 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.91174576 |
| 111 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90947883 |
| 112 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90669066 |
| 113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89462466 |
| 114 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89132734 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88786734 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88526871 |
| 117 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.87103679 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86574720 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86500349 |
| 120 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86269279 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84907580 |
| 122 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84613353 |
| 123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84060477 |
| 124 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83676709 |
| 125 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83637050 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83444215 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83340311 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82591191 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82286917 |
| 130 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82279610 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81885181 |
| 132 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.81526959 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80632956 |
| 134 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79881427 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79630577 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79630577 |
| 137 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.78768343 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78473702 |
| 139 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.76869425 |
| 140 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.76643992 |
| 141 | TCF4_23295773_ChIP-Seq_U87_Human | 0.75620065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.97775969 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.08714030 |
| 3 | MP0005360_urolithiasis | 3.99416531 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.89400306 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.40979882 |
| 6 | MP0003880_abnormal_central_pattern | 3.31895403 |
| 7 | MP0005464_abnormal_platelet_physiology | 3.23002099 |
| 8 | MP0005365_abnormal_bile_salt | 3.05415681 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 3.03683686 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.77917973 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.65532102 |
| 12 | MP0004270_analgesia | 2.62665696 |
| 13 | MP0002822_catalepsy | 2.52070081 |
| 14 | MP0009745_abnormal_behavioral_response | 2.49885201 |
| 15 | MP0004510_myositis | 2.45403807 |
| 16 | MP0003279_aneurysm | 2.44956451 |
| 17 | MP0001958_emphysema | 2.43044940 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.42278045 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.38573675 |
| 20 | MP0002064_seizures | 2.37738364 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.37201000 |
| 22 | MP0010368_abnormal_lymphatic_system | 2.36144982 |
| 23 | MP0003329_amyloid_beta_deposits | 2.35434489 |
| 24 | MP0005503_abnormal_tendon_morphology | 2.28016108 |
| 25 | MP0008004_abnormal_stomach_pH | 2.23299005 |
| 26 | MP0003566_abnormal_cell_adhesion | 2.14872973 |
| 27 | MP0005275_abnormal_skin_tensile | 2.11321110 |
| 28 | MP0010329_abnormal_lipoprotein_level | 2.07151911 |
| 29 | MP0002736_abnormal_nociception_after | 2.04692455 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.99358726 |
| 31 | MP0009046_muscle_twitch | 1.99333305 |
| 32 | MP0004272_abnormal_basement_membrane | 1.98024424 |
| 33 | MP0003252_abnormal_bile_duct | 1.96762699 |
| 34 | MP0002272_abnormal_nervous_system | 1.91614672 |
| 35 | MP0005332_abnormal_amino_acid | 1.85751897 |
| 36 | MP0001486_abnormal_startle_reflex | 1.79976560 |
| 37 | MP0002734_abnormal_mechanical_nocicepti | 1.76656031 |
| 38 | MP0004858_abnormal_nervous_system | 1.73839591 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.71907862 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.65060124 |
| 41 | MP0004084_abnormal_cardiac_muscle | 1.64209495 |
| 42 | MP0000604_amyloidosis | 1.60611428 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.60070290 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.57085791 |
| 45 | MP0006054_spinal_hemorrhage | 1.53292229 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.48442248 |
| 47 | MP0005423_abnormal_somatic_nervous | 1.48415153 |
| 48 | MP0005083_abnormal_biliary_tract | 1.43250572 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.40596415 |
| 50 | MP0003091_abnormal_cell_migration | 1.37851427 |
| 51 | MP0001970_abnormal_pain_threshold | 1.37409395 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.36225611 |
| 53 | MP0003633_abnormal_nervous_system | 1.33958636 |
| 54 | MP0003195_calcinosis | 1.33955117 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.33437193 |
| 56 | MP0002295_abnormal_pulmonary_circulatio | 1.30657680 |
| 57 | MP0008872_abnormal_physiological_respon | 1.28960685 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.28608304 |
| 59 | MP0008874_decreased_physiological_sensi | 1.28502505 |
| 60 | MP0008569_lethality_at_weaning | 1.27233662 |
| 61 | MP0000751_myopathy | 1.23276201 |
| 62 | MP0004811_abnormal_neuron_physiology | 1.20461023 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.19459486 |
| 64 | MP0004885_abnormal_endolymph | 1.18398304 |
| 65 | MP0003690_abnormal_glial_cell | 1.16368989 |
| 66 | MP0002184_abnormal_innervation | 1.16195619 |
| 67 | MP0001542_abnormal_bone_strength | 1.13961413 |
| 68 | MP0005535_abnormal_body_temperature | 1.13856450 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13566520 |
| 70 | MP0000230_abnormal_systemic_arterial | 1.13276289 |
| 71 | MP0003868_abnormal_feces_composition | 1.12755712 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.12633919 |
| 73 | MP0000013_abnormal_adipose_tissue | 1.11474397 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 1.09547665 |
| 75 | MP0005409_darkened_coat_color | 1.08754825 |
| 76 | MP0001905_abnormal_dopamine_level | 1.07913405 |
| 77 | MP0003631_nervous_system_phenotype | 1.07911645 |
| 78 | MP0008961_abnormal_basal_metabolism | 1.07714734 |
| 79 | MP0004924_abnormal_behavior | 1.07490505 |
| 80 | MP0005386_behavior/neurological_phenoty | 1.07490505 |
| 81 | MP0001348_abnormal_lacrimal_gland | 1.06303809 |
| 82 | MP0005023_abnormal_wound_healing | 1.04300281 |
| 83 | MP0000955_abnormal_spinal_cord | 1.03983564 |
| 84 | MP0002066_abnormal_motor_capabilities/c | 1.02467537 |
| 85 | MP0003879_abnormal_hair_cell | 1.01418067 |
| 86 | MP0009840_abnormal_foam_cell | 0.99324362 |
| 87 | MP0000920_abnormal_myelination | 0.98403964 |
| 88 | MP0000778_abnormal_nervous_system | 0.97557103 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.97529027 |
| 90 | MP0004130_abnormal_muscle_cell | 0.97270468 |
| 91 | MP0003075_altered_response_to | 0.96158505 |
| 92 | MP0002557_abnormal_social/conspecific_i | 0.96081490 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.95419874 |
| 94 | MP0005646_abnormal_pituitary_gland | 0.94940383 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.94052705 |
| 96 | MP0001666_abnormal_nutrient_absorption | 0.93055011 |
| 97 | MP0004142_abnormal_muscle_tone | 0.93053060 |
| 98 | MP0003191_abnormal_cellular_cholesterol | 0.92305982 |
| 99 | MP0003172_abnormal_lysosome_physiology | 0.91792636 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.88791078 |
| 101 | MP0004043_abnormal_pH_regulation | 0.88370624 |
| 102 | MP0005623_abnormal_meninges_morphology | 0.87881314 |
| 103 | MP0001984_abnormal_olfaction | 0.87513234 |
| 104 | MP0000609_abnormal_liver_physiology | 0.86813878 |
| 105 | MP0009643_abnormal_urine_homeostasis | 0.86802283 |
| 106 | MP0002882_abnormal_neuron_morphology | 0.86224378 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.85550701 |
| 108 | MP0004019_abnormal_vitamin_homeostasis | 0.85131033 |
| 109 | MP0001177_atelectasis | 0.85040488 |
| 110 | MP0005165_increased_susceptibility_to | 0.84297608 |
| 111 | MP0001502_abnormal_circadian_rhythm | 0.83826237 |
| 112 | MP0002229_neurodegeneration | 0.83782730 |
| 113 | MP0005508_abnormal_skeleton_morphology | 0.83681310 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.83548511 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.82563996 |
| 116 | MP0001849_ear_inflammation | 0.80082658 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.79494152 |
| 118 | MP0000534_abnormal_ureter_morphology | 0.79116772 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.78959944 |
| 120 | MP0002090_abnormal_vision | 0.78450148 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.77892445 |
| 122 | MP0003634_abnormal_glial_cell | 0.77636315 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.76763162 |
| 124 | MP0001661_extended_life_span | 0.75830736 |
| 125 | MP0005257_abnormal_intraocular_pressure | 0.74167478 |
| 126 | MP0005620_abnormal_muscle_contractility | 0.73778109 |
| 127 | MP0005388_respiratory_system_phenotype | 0.73503510 |
| 128 | MP0002133_abnormal_respiratory_system | 0.73503510 |
| 129 | MP0002837_dystrophic_cardiac_calcinosis | 0.72373488 |
| 130 | MP0004134_abnormal_chest_morphology | 0.70786585 |
| 131 | MP0004215_abnormal_myocardial_fiber | 0.70234693 |
| 132 | MP0004085_abnormal_heartbeat | 0.69966158 |
| 133 | MP0002972_abnormal_cardiac_muscle | 0.69747503 |
| 134 | MP0004484_altered_response_of | 0.69337011 |
| 135 | MP0009697_abnormal_copulation | 0.68772988 |
| 136 | MP0003632_abnormal_nervous_system | 0.68572138 |
| 137 | MP0002128_abnormal_blood_circulation | 0.68479957 |
| 138 | MP0004036_abnormal_muscle_relaxation | 0.68452870 |
| 139 | MP0003303_peritoneal_inflammation | 0.68374784 |
| 140 | MP0000579_abnormal_nail_morphology | 0.68287155 |
| 141 | MP0001756_abnormal_urination | 0.67628904 |
| 142 | MP0005595_abnormal_vascular_smooth | 0.66758063 |
| 143 | MP0005636_abnormal_mineral_homeostasis | 0.66541326 |
| 144 | MP0008775_abnormal_heart_ventricle | 0.65733642 |
| 145 | MP0000343_altered_response_to | 0.64218396 |
| 146 | MP0001986_abnormal_taste_sensitivity | 0.62932547 |
| 147 | MP0005171_absent_coat_pigmentation | 0.62447215 |
| 148 | MP0001851_eye_inflammation | 0.62210662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.59528547 |
| 2 | Increased mean platelet volume (HP:0011877) | 5.31662517 |
| 3 | Myokymia (HP:0002411) | 4.98843730 |
| 4 | Abnormal platelet volume (HP:0011876) | 4.95097958 |
| 5 | Focal motor seizures (HP:0011153) | 4.90851340 |
| 6 | Menorrhagia (HP:0000132) | 4.88561435 |
| 7 | Prolonged bleeding time (HP:0003010) | 4.71211951 |
| 8 | Premature rupture of membranes (HP:0001788) | 4.56186373 |
| 9 | Protrusio acetabuli (HP:0003179) | 4.30637775 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.26659612 |
| 11 | Petechiae (HP:0000967) | 4.25337655 |
| 12 | Increased circulating renin level (HP:0000848) | 4.10572655 |
| 13 | Purpura (HP:0000979) | 4.04417633 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 3.71432510 |
| 15 | Xanthomatosis (HP:0000991) | 3.63813598 |
| 16 | Focal seizures (HP:0007359) | 3.59804746 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 3.59224870 |
| 18 | Abnormality of binocular vision (HP:0011514) | 3.55492689 |
| 19 | Diplopia (HP:0000651) | 3.55492689 |
| 20 | Aortic aneurysm (HP:0004942) | 3.54099033 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.50393207 |
| 22 | Atonic seizures (HP:0010819) | 3.37022691 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.33388980 |
| 24 | Obstructive sleep apnea (HP:0002870) | 3.21677798 |
| 25 | Focal segmental glomerulosclerosis (HP:0000097) | 3.15514880 |
| 26 | Epistaxis (HP:0000421) | 3.14274249 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 3.12643038 |
| 28 | Vascular tortuosity (HP:0004948) | 3.10020500 |
| 29 | Gingival bleeding (HP:0000225) | 3.09606459 |
| 30 | Aortic dissection (HP:0002647) | 3.05118499 |
| 31 | Visual hallucinations (HP:0002367) | 3.02519838 |
| 32 | Action tremor (HP:0002345) | 3.02300219 |
| 33 | Hyperventilation (HP:0002883) | 2.97905297 |
| 34 | Follicular hyperkeratosis (HP:0007502) | 2.90896120 |
| 35 | Absence seizures (HP:0002121) | 2.85992576 |
| 36 | Glomerulosclerosis (HP:0000096) | 2.77896827 |
| 37 | Epileptic encephalopathy (HP:0200134) | 2.76341054 |
| 38 | Abnormality of the lower motor neuron (HP:0002366) | 2.75813630 |
| 39 | Increased variability in muscle fiber diameter (HP:0003557) | 2.75399774 |
| 40 | Abnormality of dentin (HP:0010299) | 2.74378461 |
| 41 | Complement deficiency (HP:0004431) | 2.71178407 |
| 42 | Slender build (HP:0001533) | 2.70530711 |
| 43 | Hypokalemic alkalosis (HP:0001949) | 2.69581502 |
| 44 | Ankle contracture (HP:0006466) | 2.68306911 |
| 45 | Lower limb amyotrophy (HP:0007210) | 2.68130302 |
| 46 | Arterial tortuosity (HP:0005116) | 2.66831512 |
| 47 | Febrile seizures (HP:0002373) | 2.66350686 |
| 48 | Type 1 muscle fiber predominance (HP:0003803) | 2.65962309 |
| 49 | Supranuclear gaze palsy (HP:0000605) | 2.65948647 |
| 50 | Cerebral hemorrhage (HP:0001342) | 2.65930518 |
| 51 | Joint hemorrhage (HP:0005261) | 2.60826453 |
| 52 | Progressive cerebellar ataxia (HP:0002073) | 2.59358046 |
| 53 | Ketosis (HP:0001946) | 2.58792587 |
| 54 | Status epilepticus (HP:0002133) | 2.56396829 |
| 55 | Alkalosis (HP:0001948) | 2.56281062 |
| 56 | Spinal rigidity (HP:0003306) | 2.55324902 |
| 57 | Generalized tonic-clonic seizures (HP:0002069) | 2.55176025 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.51081058 |
| 59 | Dialeptic seizures (HP:0011146) | 2.50091238 |
| 60 | Hypoventilation (HP:0002791) | 2.49620561 |
| 61 | Bladder diverticulum (HP:0000015) | 2.47346672 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 2.43882450 |
| 63 | Upper limb amyotrophy (HP:0009129) | 2.43882450 |
| 64 | Mild short stature (HP:0003502) | 2.42638182 |
| 65 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42326921 |
| 66 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.41384653 |
| 67 | Hyperammonemia (HP:0001987) | 2.40833623 |
| 68 | Abnormal platelet function (HP:0011869) | 2.39580527 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.39580527 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.39241915 |
| 71 | Torticollis (HP:0000473) | 2.39054176 |
| 72 | Atrophic scars (HP:0001075) | 2.38064302 |
| 73 | Gout (HP:0001997) | 2.36997459 |
| 74 | Neonatal onset (HP:0003623) | 2.35934242 |
| 75 | Bowel diverticulosis (HP:0005222) | 2.34670713 |
| 76 | Broad metatarsal (HP:0001783) | 2.33894521 |
| 77 | Scanning speech (HP:0002168) | 2.33450143 |
| 78 | Cerebral inclusion bodies (HP:0100314) | 2.31893387 |
| 79 | Epidermoid cyst (HP:0200040) | 2.31803131 |
| 80 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.31448529 |
| 81 | Papilledema (HP:0001085) | 2.31402649 |
| 82 | Annular pancreas (HP:0001734) | 2.30303344 |
| 83 | Potter facies (HP:0002009) | 2.30292211 |
| 84 | Facial shape deformation (HP:0011334) | 2.30292211 |
| 85 | Wormian bones (HP:0002645) | 2.29568844 |
| 86 | Focal dystonia (HP:0004373) | 2.28646696 |
| 87 | Hemiplegia (HP:0002301) | 2.28428107 |
| 88 | Hyperglycinemia (HP:0002154) | 2.28125433 |
| 89 | Soft skin (HP:0000977) | 2.25536173 |
| 90 | Hypomagnesemia (HP:0002917) | 2.23332930 |
| 91 | Tetraplegia (HP:0002445) | 2.22760596 |
| 92 | Impaired social interactions (HP:0000735) | 2.22645290 |
| 93 | Abnormal social behavior (HP:0012433) | 2.22645290 |
| 94 | Termporal pattern (HP:0011008) | 2.21492872 |
| 95 | Insidious onset (HP:0003587) | 2.21492872 |
| 96 | Dilatation of the ascending aorta (HP:0005111) | 2.20909402 |
| 97 | Glomerulonephritis (HP:0000099) | 2.20162264 |
| 98 | Cholecystitis (HP:0001082) | 2.20031365 |
| 99 | Abnormal gallbladder physiology (HP:0012438) | 2.20031365 |
| 100 | Fragile skin (HP:0001030) | 2.19961830 |
| 101 | Craniofacial dystonia (HP:0012179) | 2.19680386 |
| 102 | Dysmetria (HP:0001310) | 2.18912007 |
| 103 | Genu recurvatum (HP:0002816) | 2.18716117 |
| 104 | Spontaneous hematomas (HP:0007420) | 2.18481285 |
| 105 | Hypolipoproteinemia (HP:0010981) | 2.17522317 |
| 106 | Neonatal short-limb short stature (HP:0008921) | 2.15886492 |
| 107 | Spontaneous abortion (HP:0005268) | 2.15668741 |
| 108 | Pheochromocytoma (HP:0002666) | 2.15294507 |
| 109 | Anxiety (HP:0000739) | 2.14655135 |
| 110 | Distal lower limb amyotrophy (HP:0008944) | 2.14052598 |
| 111 | Lower limb muscle weakness (HP:0007340) | 2.14041258 |
| 112 | Abnormal eating behavior (HP:0100738) | 2.13004210 |
| 113 | Delayed CNS myelination (HP:0002188) | 2.12801785 |
| 114 | Nephritis (HP:0000123) | 2.10574428 |
| 115 | Ankle clonus (HP:0011448) | 2.09453655 |
| 116 | Shallow orbits (HP:0000586) | 2.07959153 |
| 117 | Vascular calcification (HP:0004934) | 2.06569824 |
| 118 | Bruising susceptibility (HP:0000978) | 2.06236426 |
| 119 | Depression (HP:0000716) | 2.05531732 |
| 120 | Sensorimotor neuropathy (HP:0007141) | 2.04201289 |
| 121 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.03946319 |
| 122 | Overgrowth (HP:0001548) | 2.02616423 |
| 123 | Fat malabsorption (HP:0002630) | 2.01858868 |
| 124 | Hand muscle atrophy (HP:0009130) | 2.00843715 |
| 125 | Spastic gait (HP:0002064) | 2.00743689 |
| 126 | Poor eye contact (HP:0000817) | 2.00347049 |
| 127 | Urinary urgency (HP:0000012) | 1.98843084 |
| 128 | Mesangial abnormality (HP:0001966) | 1.98133529 |
| 129 | Ketoacidosis (HP:0001993) | 1.97304609 |
| 130 | Hypoplasia of the iris (HP:0007676) | 1.96858693 |
| 131 | Mitral stenosis (HP:0001718) | 1.96525374 |
| 132 | Postural instability (HP:0002172) | 1.94726276 |
| 133 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94264998 |
| 134 | Rapidly progressive (HP:0003678) | 1.93991623 |
| 135 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.93580828 |
| 136 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93520504 |
| 137 | Intention tremor (HP:0002080) | 1.92584850 |
| 138 | Clonus (HP:0002169) | 1.92192929 |
| 139 | Truncal ataxia (HP:0002078) | 1.92136370 |
| 140 | Abnormality of renin-angiotensin system (HP:0000847) | 1.91498830 |
| 141 | Bundle branch block (HP:0011710) | 1.91250646 |
| 142 | Hypoalphalipoproteinemia (HP:0003233) | 1.91132436 |
| 143 | Abnormality of magnesium homeostasis (HP:0004921) | 1.90644173 |
| 144 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.90435062 |
| 145 | Abnormality of glycine metabolism (HP:0010895) | 1.90435062 |
| 146 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.89544794 |
| 147 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.88861362 |
| 148 | Dysdiadochokinesis (HP:0002075) | 1.87966602 |
| 149 | Polycythemia (HP:0001901) | 1.86876682 |
| 150 | Neuroendocrine neoplasm (HP:0100634) | 1.86421779 |
| 151 | Hammertoe (HP:0001765) | 1.86309429 |
| 152 | Abnormality of methionine metabolism (HP:0010901) | 1.85925202 |
| 153 | Blue irides (HP:0000635) | 1.85702007 |
| 154 | Peritonitis (HP:0002586) | 1.85307200 |
| 155 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84375703 |
| 156 | Blue sclerae (HP:0000592) | 1.84315084 |
| 157 | Abnormality of the corticospinal tract (HP:0002492) | 1.83808750 |
| 158 | Insomnia (HP:0100785) | 1.80676193 |
| 159 | Hyperextensible skin (HP:0000974) | 1.80194392 |
| 160 | Conjunctival telangiectasia (HP:0000524) | 1.79565169 |
| 161 | Amyloidosis (HP:0011034) | 1.79557170 |
| 162 | Delusions (HP:0000746) | 1.79324043 |
| 163 | Cardiovascular calcification (HP:0011915) | 1.78821531 |
| 164 | Mitral regurgitation (HP:0001653) | 1.76394705 |
| 165 | Abnormal atrioventricular conduction (HP:0005150) | 1.74509958 |
| 166 | Neuronal loss in central nervous system (HP:0002529) | 1.71908645 |
| 167 | Spinal canal stenosis (HP:0003416) | 1.70014175 |
| 168 | Mitral valve prolapse (HP:0001634) | 1.69713400 |
| 169 | Abnormality of the Achilles tendon (HP:0005109) | 1.69678421 |
| 170 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.67063841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 4.14662780 |
| 2 | NTRK3 | 3.72470556 |
| 3 | STK39 | 3.36592249 |
| 4 | OXSR1 | 3.07899894 |
| 5 | EPHA4 | 2.64557204 |
| 6 | MAP3K9 | 2.54371918 |
| 7 | TIE1 | 2.53511924 |
| 8 | MAP3K4 | 2.35432967 |
| 9 | MINK1 | 2.30198326 |
| 10 | KSR2 | 2.17978548 |
| 11 | MAP2K4 | 2.14024230 |
| 12 | DAPK2 | 1.91974741 |
| 13 | MAP3K12 | 1.83673939 |
| 14 | NTRK1 | 1.79418769 |
| 15 | KDR | 1.78038591 |
| 16 | PAK6 | 1.67885387 |
| 17 | MAP3K13 | 1.60579565 |
| 18 | MAP2K7 | 1.58131110 |
| 19 | BMX | 1.54024034 |
| 20 | FGFR4 | 1.46650829 |
| 21 | DDR2 | 1.42919237 |
| 22 | MARK1 | 1.41508146 |
| 23 | PRKCH | 1.32740385 |
| 24 | NTRK2 | 1.32263806 |
| 25 | FES | 1.31592958 |
| 26 | KSR1 | 1.28648229 |
| 27 | ARAF | 1.27256002 |
| 28 | CASK | 1.23928278 |
| 29 | DAPK3 | 1.21975621 |
| 30 | PAK2 | 1.17927878 |
| 31 | SGK494 | 1.15375178 |
| 32 | SGK223 | 1.15375178 |
| 33 | GRK5 | 1.14847684 |
| 34 | PRKD3 | 1.13136742 |
| 35 | CDK5 | 1.10409922 |
| 36 | CAMKK1 | 1.09906157 |
| 37 | STK38 | 1.09061763 |
| 38 | RET | 1.05770054 |
| 39 | PTK2B | 1.05713590 |
| 40 | TESK1 | 1.04703696 |
| 41 | MAP3K2 | 1.03915297 |
| 42 | LMTK2 | 1.03019795 |
| 43 | MAP3K7 | 0.98823673 |
| 44 | PTK2 | 0.98673418 |
| 45 | PIK3CG | 0.98614271 |
| 46 | LIMK1 | 0.96770854 |
| 47 | PRKCG | 0.95974998 |
| 48 | SGK3 | 0.95603782 |
| 49 | SGK2 | 0.95018552 |
| 50 | CAMK2B | 0.94812767 |
| 51 | TYRO3 | 0.94216066 |
| 52 | SIK2 | 0.94210365 |
| 53 | PAK3 | 0.94181876 |
| 54 | TGFBR2 | 0.93550265 |
| 55 | LATS2 | 0.89731269 |
| 56 | NEK9 | 0.89214982 |
| 57 | PRKD2 | 0.88606957 |
| 58 | ROCK2 | 0.88112449 |
| 59 | SIK3 | 0.88068670 |
| 60 | BMPR2 | 0.87785767 |
| 61 | FER | 0.87570891 |
| 62 | SIK1 | 0.87096747 |
| 63 | DAPK1 | 0.86482747 |
| 64 | PDPK1 | 0.83434075 |
| 65 | ROCK1 | 0.81398687 |
| 66 | PNCK | 0.79945461 |
| 67 | PDK1 | 0.79283627 |
| 68 | PRPF4B | 0.78978056 |
| 69 | PHKG1 | 0.77005099 |
| 70 | PHKG2 | 0.77005099 |
| 71 | WNK1 | 0.75986045 |
| 72 | MAPK12 | 0.75812032 |
| 73 | PRKD1 | 0.74215549 |
| 74 | PDGFRB | 0.74079606 |
| 75 | CAMK2A | 0.74074035 |
| 76 | MAP3K1 | 0.72805217 |
| 77 | PLK2 | 0.71323004 |
| 78 | TTN | 0.70816805 |
| 79 | TEC | 0.70605703 |
| 80 | PRKG2 | 0.69571829 |
| 81 | DYRK1A | 0.69390135 |
| 82 | ADRBK1 | 0.68079623 |
| 83 | SYK | 0.67399609 |
| 84 | CDK11A | 0.66846182 |
| 85 | PAK1 | 0.66774594 |
| 86 | FGFR2 | 0.66645306 |
| 87 | MAP2K1 | 0.66620154 |
| 88 | GRK6 | 0.65727564 |
| 89 | BRAF | 0.65692489 |
| 90 | CSNK1G2 | 0.64811542 |
| 91 | MYLK | 0.64749378 |
| 92 | JAK1 | 0.64159005 |
| 93 | MAP3K11 | 0.63795263 |
| 94 | CAMK1 | 0.63611071 |
| 95 | TAOK2 | 0.63102041 |
| 96 | MAPK13 | 0.62727881 |
| 97 | CDK19 | 0.61715165 |
| 98 | CAMK2G | 0.60420332 |
| 99 | PINK1 | 0.59574732 |
| 100 | STK11 | 0.58833271 |
| 101 | MARK2 | 0.58517370 |
| 102 | BCKDK | 0.56727641 |
| 103 | PDGFRA | 0.56622324 |
| 104 | BLK | 0.56617570 |
| 105 | RAF1 | 0.54861730 |
| 106 | DMPK | 0.53330767 |
| 107 | ZAP70 | 0.52673211 |
| 108 | PRKCQ | 0.52459862 |
| 109 | JAK3 | 0.51867152 |
| 110 | PRKCZ | 0.51852275 |
| 111 | UHMK1 | 0.49928483 |
| 112 | RIPK4 | 0.48957325 |
| 113 | RPS6KA2 | 0.47891003 |
| 114 | CDK14 | 0.47349096 |
| 115 | CDC42BPA | 0.46577076 |
| 116 | MOS | 0.45848852 |
| 117 | JAK2 | 0.45140821 |
| 118 | CDK18 | 0.45055970 |
| 119 | PKN1 | 0.44713834 |
| 120 | EPHB2 | 0.44163505 |
| 121 | MAPK10 | 0.44110826 |
| 122 | FYN | 0.44006201 |
| 123 | CAMK4 | 0.43903720 |
| 124 | PRKCE | 0.43639637 |
| 125 | SGK1 | 0.43181818 |
| 126 | CAMKK2 | 0.42571194 |
| 127 | CDK15 | 0.42557291 |
| 128 | TAOK1 | 0.42013300 |
| 129 | CAMK1G | 0.41928925 |
| 130 | TNK2 | 0.40070530 |
| 131 | MAPK7 | 0.39887436 |
| 132 | FGFR3 | 0.37287163 |
| 133 | TNIK | 0.36571657 |
| 134 | RIPK1 | 0.36250539 |
| 135 | AKT3 | 0.35152237 |
| 136 | RPS6KA3 | 0.34025916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.61983933 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.98669784 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83493240 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44564808 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.26312659 |
| 6 | Platelet activation_Homo sapiens_hsa04611 | 2.03186631 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.96720836 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.96472062 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.91923256 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 1.85632409 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.75386310 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75061827 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.71781230 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68691037 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67395817 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.65287852 |
| 17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.61592574 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58284801 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.55589985 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.49089222 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.47834833 |
| 22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.44690486 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.44600820 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43676495 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38114762 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.37809443 |
| 27 | Long-term potentiation_Homo sapiens_hsa04720 | 1.37767897 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.33695848 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33467529 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.30578957 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.29875798 |
| 32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.29751421 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.27912673 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.27719254 |
| 35 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20589600 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17797299 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 1.14945797 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14375310 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14138319 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14009868 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13802990 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13802069 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13272456 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.09018324 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.07661342 |
| 46 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.07546985 |
| 47 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06270972 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98796587 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 0.98415708 |
| 50 | * Endocytosis_Homo sapiens_hsa04144 | 0.98323076 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.98263218 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.97871022 |
| 53 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.97732740 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.95551565 |
| 55 | Taste transduction_Homo sapiens_hsa04742 | 0.95322610 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.94783927 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92771476 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92723831 |
| 59 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.92512087 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91775250 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.88358137 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87885630 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86348295 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84571359 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83979806 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82872175 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82355688 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82316517 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80264888 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79998175 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79800686 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.79298340 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.79053651 |
| 74 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79018393 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78841448 |
| 76 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78806885 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.78175875 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76302484 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75992827 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74185245 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73423838 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72671534 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72273124 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.69928694 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69638671 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69627786 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69502632 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68414737 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68279036 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68068274 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.67204072 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67087887 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66897794 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66781281 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.66702044 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66303448 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65321100 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62100515 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61776636 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61412560 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60572846 |
| 102 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.59807824 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58923979 |
| 104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58505942 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58365479 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58333931 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57495768 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.57093530 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56596361 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55901676 |
| 111 | Melanoma_Homo sapiens_hsa05218 | 0.55519060 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54887975 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.54561347 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54290198 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53644437 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.52767865 |
| 117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52649964 |
| 118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51970551 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50840679 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.50467953 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50393633 |
| 122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50174445 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48990259 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47879438 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.47582021 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47549814 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46640691 |
| 128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46052404 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46011839 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44524255 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44267724 |
| 132 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43916276 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43367585 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43264236 |
| 135 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42991057 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42568951 |
| 137 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41371099 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40446698 |
| 139 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39924848 |
| 140 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39267549 |
| 141 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39088453 |
| 142 | Melanogenesis_Homo sapiens_hsa04916 | 0.38478104 |
| 143 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36750777 |
| 144 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36565701 |
| 145 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35769106 |
| 146 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34905411 |
| 147 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34778754 |

